Loading organizations...
Loading organizations...
Biotech company developing treatments for neurodegenerative diseases.
Neuraly has raised $36.0M across 1 funding round.
Neuraly has raised $36.0M in total across 1 funding round.
Neuraly has raised $36.0M in total across 1 funding round.
Neuraly's investors include D&D Pharmatech, Dongkoo Bio&Pharma, Geon Investment, Junghee Lim, LB Investment, Keele Park, Phillip Jung, Octave Life Sciences, John Ku.
Neuraly has raised $36.0M across 1 funding round. Most recently, it raised $36.0M Series A in July 2018.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 18, 2018 | $36.0M Series A | D&D Pharmatech | Dongkoo Bio&Pharma, Geon Investment, Junghee Lim, LB Investment, Keele Park, Phillip Jung, Octave Life Sciences, John Ku |